352 results on '"Vila, V."'
Search Results
2. Clinical–epidemiological profile of the patient attended in a Fracture Liaison Service (FLS) of a regional hospital in north-west of Spain
3. Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation
4. OP0229 CHANGES IN THE CAUSES AND PREDICTORS OF LUPUS MORTALITY IN SPAIN THROUGH THE LAST DECADES: DATA FROM THE RELESSER REGISTRY
5. [Translated article] Clinical–epidemiological profile of the patient attended in a Fracture Liaison Service (FLS) of a regional hospital in north-west of Spain
6. Signature of Accidental Symmetry Breaking in Two-particle Correlations within the CGC
7. Clinical–epidemiological profile of the patient attended in a Fracture Liaison Service (FLS) of a regional hospital in north-west of Spain
8. S09.3 Changes in the causes and predictors of lupus mortality in Spain through the last decades: data from the relesser registry
9. Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?
10. POS1101 DAPSA CORRECTED FOR PsAID12 IMPROVES ITS CONCORDANCE WITH MINIMAL DISEASE ACTIVITY.
11. AB0959 The activity of psoriatic arthritis with axial involvement correlates with PsAID12.
12. Prevalence of symptomatic axial osteoarthritis phenotypes in Spain and associated socio-demographic, anthropometric, and lifestyle variables
13. LA HARINA DE LOMBRIZ DE TIERRA (EISENIA FETIDA) COMO ALTERNATIVA PROTEICA EN EL ENGORDE DE PRE-JUVENILES DEL CAMAR��N PENAEUS
14. Clinical–epidemiological profile of the patient attended in a Fracture Liaison Service (FLS) of a regional hospital in north-west of Spain
15. VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer
16. Evaluation of a rejuvenator as an additive in asphalt
17. Prevalence of symptomatic axial osteoarthritis phenotypes in Spain and associated socio-demographic, anthropometric, and lifestyle variables
18. La interpretación de género en la comedia palatina: el travestismo en 'Las manos blancas no ofenden'
19. ARE ANTIMALARIALS SAFE FOR THE HEART OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS? ANALYSIS OF FACTORS ASSOCIATED WITH THE DEVELOPMENT OF HEART FAILURE IN PATIENTS IN THE SPANISH SOCIETY OF RHEUMATOLOGY LUPUS REGISTRY (RELESSER)
20. AB0577 METABOLIC SYNDROME IN PSORIATIC ARTHRITIS SEEMS ASSOCIATED TO INFLAMMATORY STATUS OF THE DISEASE
21. POS0721 ARE ANTIMALARIALS SAFE FOR THE HEART OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS? ANALYSIS OF FACTORS ASSOCIATED WITH THE DEVELOPMENT OF HEART FAILURE IN PATIENTS IN THE SPANISH SOCIETY OF RHEUMATOLOGY LUPUS REGISTRY (RELESSER)
22. Ibero-latinamerican clinical practical guidelines on pediatric caustic esophagitis: Physiopathology and clinical-endoscopic diagnosis (1st Part)
23. Associated factors to serious infections in a large cohort of juvenile-onset systemic lupus erythematosus from Lupus Registry (RELESSER)
24. Differences in clinical manifestations and increased severity of systemic lupus erythematosus between two groups of Hispanics: European Caucasians versus Latin American mestizos (data from the RELESSER registry)
25. Prevalence of symptomatic osteoarthritis in Spain: EPISER2016 study
26. FACTORS AFFECTING MORTALITY OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS IN SPAIN IN THE 21ST CENTURY: DATA FROM THE RELESSER REGISTRY
27. Ibero-Latinamerican Clinical Practical Guidelines on pediatric caustic esophagitis: Therapeutical aspects (Part 2)
28. Gastrointestinal Disease in SLE: Does It Indicate a Worse Prognosis?
29. The prevalence of rheumatoid arthritis in Spain
30. Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method
31. Differential clinical characteristics and prognosis of intraventricular conduction defects in patients with chronic heart failure
32. Biological markers in the progression of asymptomatic carotid stenosis: PB 2.30–6
33. Thrombin generation assay by calibrated automated thrombogram (CAT): application to monitoring severe hemophilia A treatment: PB 1.38–3
34. Increased circulating microparticles and endothelial cells in patients with psoriasis: PB 1.30–1
35. Procoagulant microparticles in cancer patients: prognostic value: PB 1.28
36. Assessment of the thrombin generation assay in haemophilia: Comparative study between fresh and frozen platelet-rich plasma
37. SAT0221 FACTORS AFFECTING MORTALITY OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS IN SPAIN IN THE 21ST CENTURY: DATA FROM THE RELESSER REGISTRY
38. Anterior pituitary development and Pit-1/GHF-1 transcription factor
39. What is the best biomarker for diagnosis of rejection in heart transplantation?
40. The stigma of burns: Perceptions of burned patients’ relatives when facing discharge from hospital
41. La atorvastaina modula a la trombospondina en células endoteliales umbilicales humanas
42. DO ALL ANTIPHOSPHOLIPID ANTIBODIES CONFER THE SAME RISK FOR MAJOR ORGAN INVOLVEMENT IN SLE PATIENTS?
43. ANTIPHOSPHOLIPID SYNDROME (APS) IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) LEADS TO A MORE SEVERE DISEASE
44. Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems
45. Optimal schedule for cancer chemotherapy
46. Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation
47. Changes in osteocalcin response to 1,25-dihydroxyvitamin D 3 stimulation and basal vitamin D receptor expression in human osteoblastic cells according to donor age and skeletal origin
48. [Reseña] Pedro Calderón de la Barca, El laberinto del mundo
49. Increased circulating endothelial cells and microparticles in patients with psoriasis
50. Dos versiones de la primera jornada de ‘Las manos blancas no ofenden’ de Calderón de la Barca
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.